BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR+91.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+91.9%/yr
vs -30.3%/yr prior
Acceleration
+122.2pp
Accelerating
Percentile
P71
Within normal range
vs 3Y Ago
7.1x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 23.39% |
| 2024 | 0.06% |
| 2023 | 14.96% |
| 2022 | 3.31% |
| 2021 | 0.11% |
| 2020 | -12.15% |
| 2019 | 2.68% |
| 2018 | 14.01% |
| 2017 | -7.73% |
| 2016 | 4.27% |